Source: PharmaLive 25 October 2010 Today, GlaxoSmithKline Inc. (Canada), announced its plan to reduce the cost of CERVARIX™ by 30%. The cost reduction is in response to recent research that demonstrates the relatively high price of cervical cancer vaccines, coupled with a low understanding of their protective benefits topped the list of reasons why the […]
Gardasil Anal Cancer Indication to Face FDA Advisory Committee Scrutiny
By: S. Sutter 27 September 2010 Merck’s bid to further expand the label for its human papillomavirus vaccine Gardasil – this time for the prevention of anal cancer and anal dysplasia – will face FDA advisory committee scrutiny in November. The Vaccines and Related Biological Products Advisory Committee will meet on Nov. 17 to discuss […]
Teenage Girls & Boys at Risk from Gardasil: The New Killer Vaccine
By: Maria Muir 28 August 2010 Previously reported on this blog regarding Gardasil: The HPV vaccine fraud as Gardasil reaches Irish schools Merck & Co., Inc., manufacturer of the human papillomavirus (HPV) vaccine Gardasil are still pushing the vaccine on teenage girls and more recently and shockingly, aiming at teenage boys. Apparently it is being […]
- « Previous Page
- 1
- …
- 56
- 57
- 58
